| 2025-08-20 | HEIDEN WILLIAM K | Director | Buy | 100,000 | $1.51 | $150,515.00 | +137.9% | → |
| 2025-02-15 | Smith Beth Ann | VP, Controller & Treasurer | Sale+OE | 423 | $2.56 | $1,082.88 | -4.2% | → |
| 2024-04-04 | Peters Jeffrey Stuart | Senior VP and General Counsel | Sale+OE | 51,395 | $15.55 | $799,148.17 | -63.7% | → |
| 2024-03-06 | Peters Jeffrey Stuart | Senior VP and General Counsel | Sale+OE | 19,625 | $21.50 | $421,937.50 | -68.8% | → |
| 2024-03-04 | Risser Eric Blasius | Chief Operating Officer | Sale+OE | 41,159 | $19.76 | $813,501.17 | -28.4% | → |
| 2024-03-04 | Karrels James | SVP, CFO and Secretary | Sell | 30,000 | $20.50 | $615,000.00 | -14.9% | → |
| 2024-03-04 | Spitznagel Thomas | Sr VP, Technical Ops | Sale+OE | 10,000 | $20.00 | $200,000.00 | -54.6% | → |
| 2024-02-26 | Peters Jeffrey Stuart | Senior VP and General Counsel | Sell | 16,124 | $17.22 | $277,655.28 | -64.4% | → |
| 2024-02-07 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 3,334 | $18.00 | $60,012.00 | -4.5% | → |
| 2024-02-05 | Peters Jeffrey Stuart | Senior VP and General Counsel | Sale+OE | 76,251 | $16.50 | $1,258,141.50 | -77.7% | → |
| 2024-02-01 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 13,316 | $15.00 | $199,740.00 | -15.1% | → |
| 2024-01-19 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 13,316 | $12.00 | $159,792.00 | -13.1% | → |
| 2023-12-20 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 18,880 | $10.08 | $190,310.40 | -15.7% | → |
| 2023-10-02 | BIOTECH TARGET N V | - | Buy | 150,000 | $4.46 | $669,585.00 | +1.5% | → |
| 2023-09-07 | BIOTECH TARGET N V | - | Buy | 200,000 | $5.26 | $1,052,840.00 | +2.1% | → |
| 2023-08-30 | HURWITZ EDWARD | - | Buy | 15,000 | $4.91 | $73,650.00 | +83.0% | → |
| 2023-03-10 | Peters Jeffrey Stuart | Senior VP and General Counsel | Sell | 5,372 | $6.03 | $32,393.16 | -100% | → |
| 2023-02-14 | BIOTECH TARGET N V | - | Buy | 500,000 | $5.07 | $2,532,600.00 | +5.5% | → |
| 2023-01-19 | BIOTECH TARGET N V | - | Buy | 150,000 | $5.30 | $794,925.00 | +1.7% | → |
| 2022-12-27 | BIOTECH TARGET N V | - | Buy | 400,000 | $5.75 | $2,298,600.00 | +2.3% | → |
| 2022-11-22 | BIOTECH TARGET N V | - | Buy | 300,000 | $5.96 | $1,788,180.00 | +3.6% | → |
| 2022-10-24 | BIOTECH TARGET N V | - | Buy | 500,000 | $4.50 | $2,247,600.00 | +3.2% | → |
| 2022-10-20 | BIOTECH TARGET N V | - | Buy | 454,399 | $3.89 | $1,767,484.13 | +3.1% | → |
| 2022-06-15 | Karrels James | SVP, CFO and Secretary | Buy | 40,000 | $2.47 | $98,800.00 | +26.4% | → |
| 2021-11-19 | BIOTECH TARGET N V | - | Buy | 200,000 | $18.50 | $3,700,320.00 | +2.8% | → |
| 2021-09-29 | BIOTECH TARGET N V | - | Buy | 200,000 | $20.56 | $4,111,420.00 | +1.4% | → |
| 2021-09-17 | BIOTECH TARGET N V | - | Buy | 600,000 | $20.61 | $12,363,480.00 | +4.6% | → |
| 2021-07-16 | Spitznagel Thomas | Sr VP, BPD & Manufacturing | Sale+OE | 5,000 | $25.01 | $125,050.00 | -100% | → |
| 2021-06-21 | BIOTECH TARGET N V | - | Buy | 75,000 | $21.74 | $1,630,170.00 | +1.2% | → |
| 2021-06-16 | BIOTECH TARGET N V | - | Buy | 175,000 | $20.82 | $3,644,005.00 | +1.4% | → |
| 2021-04-15 | Spitznagel Thomas | Sr VP, BPD & Manufacturing | Sale+OE | 5,000 | $30.91 | $154,550.00 | -100% | → |
| 2021-03-22 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 3,917 | $32.00 | $125,344.00 | -4.7% | → |
| 2021-03-22 | Karrels James | SVP, CFO and Secretary | Sell | 15,000 | $33.00 | $495,000.00 | -9.5% | → |
| 2021-03-08 | Peters Jeffrey Stuart | General Counsel | Sale+OE | 21,749 | $26.50 | $576,348.50 | -100% | → |
| 2020-12-29 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sale+OE | 500 | $24.10 | $12,050.00 | -1.1% | → |
| 2020-11-30 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sale+OE | 500 | $23.35 | $11,675.00 | -1.1% | → |
| 2020-10-28 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sale+OE | 1,500 | $20.69 | $31,035.00 | -3.3% | → |